8-26-13 3:47 PM EDT | Email Article
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1045846&ProfileId=051205&sourceType=1

MIAMI, FL -- (Marketwired) -- 08/26/13 -- SK3 Group, Inc. (PINKSHEETS: SKTO) announces that its Investor relations consultant, Rubicon Capital Advisors has completed a dedicated web, phone and email presence for SKTO shareholder information. The new telephone # is 855-868-7577 (Dial 1 for direct IR)

"Having a dedicated team addressing all our shareholder inquiries will assist in allowing our team execute on the day-to-day value actions, however we will be in close contact on all matters related to investor and shareholder relations. We would ask at this time that shareholders only use this telephone number and email, again allowing our team to concentrate on bringing value to our core business," comments Mr. A Mayor, President, SK3 Group.

Additionally, SK3 is still preparing for the distribution of the stock held in Alternative Energy Partners, which is expected be completed very soon. As was previously announced, this distribution of stock to the shareholders required that the shares be registered with the SEC before the distribution, a process which AEGY has agreed to undertake. This registration is a complex, expensive and time-consuming process and requires the completion of SEC review after filing, and the clearance of a Notice of Corporate Action filed with FINRA before it is effective. We are advised that AEGY will have the registration statement filed shortly, although an audit of its financial statements for its fiscal year ended July 31, 2013, must be completed before filing. Frequent updates will be made available as to the audit completion and effectiveness of the S1 in real time as The Company receives the latest information.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Investor Relations Contact
joanne@rubiconcapitaladvisors.com
TEL: 855-868-7577 ( Dial 1 for direct IR)
www.rubiconcapitaladvisors.com


Add a Comment

News   More...

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Content Partners
Morningstar - - SK3 Group Announces New Dedicated Investor Relation Contacts, Comments on AEGY Distribution
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Author |  Collection |  Interest |  Popularity

Previous: SK3 Group (SKTO) Announces Licensing of Proprietary Cryo-Extraction Technique for Extracting Non-Psychoactive Cannabinoids  |  Next: SK3 Group Completes Beta Testing of Broad Use T-Hydrocan(TM) and Prepares for Distribution to Collectives and Pharmajanes.com